Alerts will be sent to your verified email
Verify Email3BBLACKBIO
|
3B Blackbio Dx
|
TTK Healthcare
|
Nureca
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
30.57 % | 19.91 % | 4.74 % |
|
5yr average Equity Multiplier
|
1.21 | 1.3 | 1.09 |
|
5yr Average Asset Turnover Ratio
|
0.5 | 0.72 | 0.66 |
|
5yr Avg Net Profit Margin
|
44.97 % | 24.27 % | 2.08 % |
|
Price to Book
|
3.33 | 1.25 | 1.44 |
|
P/E
|
18.41 | 21.24 | 124.75 |
|
5yr Avg Cash Conversion Cycle
|
128.05 Days | -3.67 Days | 90.04 Days |
|
Inventory Days
|
30.75 Days | 43.41 Days | 109.16 Days |
|
Days Receivable
|
137.66 Days | 41.32 Days | 12.7 Days |
|
Days Payable
|
46.71 Days | 110.17 Days | 25.4 Days |
|
5yr Average Interest Coverage Ratio
|
440.19 | 23.15 | 12.64 |
|
5yr Avg ROCE
|
37.21 % | 8.03 % | 5.66 % |
|
5yr Avg Operating Profit Margin
|
51.13 % | 4.06 % | -1.98 % |
|
5 yr average Debt to Equity
|
0.01 | 0.03 | 0.0 |
|
5yr CAGR Net Profit
|
-15.98 % | 9.57 % | -45.92 % |
|
5yr Average Return on Assets
|
23.36 % | 15.8 % | 2.88 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
40.95 % | 74.56 % | 68.09 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
2.52 % | 0.0 | 5.11 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | -2.98 % | 0.0 |
|
3B Blackbio Dx
|
TTK Healthcare
|
Nureca
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|